Structure-activity relationship in the 3-iodo-4-phenoxypyridinone (IOPY) series: The nature of the C-3 substituent on anti-HIV activity

被引:18
作者
Benjahad, Abdellah
Oumouch, Said
Guillemont, Jerome
Pasquier, Elisabeth
Mabire, Dominique
Andries, Koen
Nguyen, Chi Hung
Grierson, David S.
机构
[1] Inst Curie, UMR CNRS 176, Lab Pharmacochim, Sect Rech,Ctr Univ, F-91405 Orsay, France
[2] Johnson & Johnson Pharmaceut Res & Dev, Med Chem Dept, Val De Reuil, France
[3] Johnson & Johnson Pharmaceut Res & Dev, Virol Drug Discovery, B-2340 Beerse, Belgium
关键词
NNRTI; pyridinone; IOPY; anti-HIV;
D O I
10.1016/j.bmcl.2006.10.082
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As part of a systematic SAR study on the 3-iodo-4-phenoxypyridinone 3 (IOPY) type non-nucleoside reverse transcriptase inhibitors, the analogues 4a-4z bearing different C-3 substituents were synthesized and evaluated for their anti-HIV activity against wild-type HIV-1 and four of the principal HIV mutant strains (K103N, Y181C, Y188L, and 1100L). The results show that the 3-vinyl analogue 4j is the only compound which displays anti-HIV activity comparable to IOPY 3, and in this respect represents a possible back-up to this lead molecule. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:712 / 716
页数:5
相关论文
共 12 条
[1]   3-Iodo-4-phenoxypyridinones (IOPY's), a new family of highly potent non-nucleoside inhibitors of HIV-1 reverse transcriptase [J].
Benjahad, A ;
Guillemont, J ;
Andries, K ;
Nguyen, CH ;
Grierson, DS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (24) :4309-4312
[2]  
BISHOP, 1952, J CHEM SOC, P437
[3]  
CASTRO BR, 1983, ORG REACTIONS, V29, P1
[4]   METHYL FLUOROSULFONYLDIFLUOROACETATE - A NEW TRIFLUOROMETHYLATING AGENT [J].
CHEN, QY ;
WU, SW .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1989, (11) :705-706
[5]   TRANSITION-METAL MEDIATED THIATION OF AROMATIC RINGS [J].
DICKENS, MJ ;
GILDAY, JP ;
MOWLEM, TJ ;
WIDDOWSON, DA .
TETRAHEDRON, 1991, 47 (40) :8621-8634
[6]   A NEW SERIES OF PYRIDINONE DERIVATIVES AS POTENT NONNUCLEOSIDE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS [J].
DOLLE, V ;
FAN, E ;
NGUYEN, CH ;
AUBERTIN, AM ;
KIRN, A ;
ANDREOLA, ML ;
JAMIESON, G ;
TARRAGOLITVAK, L ;
BISAGNI, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (23) :4679-4686
[7]   Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: A new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains [J].
Himmel, DM ;
Das, K ;
Clark, AD ;
Hughes, SH ;
Benjahad, A ;
Oumouch, S ;
Guillemont, J ;
Coupa, S ;
Poncelet, A ;
Csoka, I ;
Meyer, C ;
Andries, K ;
Nguyen, CH ;
Grierson, DS ;
Arnold, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7582-7591
[8]   Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants [J].
Hopkins, AL ;
Ren, JS ;
Tanaka, H ;
Baba, M ;
Okamato, M ;
Stuart, DI ;
Stammers, DK .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (22) :4500-4505
[9]   Remote pummerer reaction via intermolecular through-space interaction between sulfonium and sulfenyl sulfur atoms [J].
Kobayashi, K ;
Koyama, E ;
Namatame, K ;
Kitaura, T ;
Kono, C ;
Goto, M ;
Obinata, T ;
Furukawa, N .
JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (09) :3190-3195
[10]   THE USE OF DIETHYL AZODICARBOXYLATE AND TRIPHENYLPHOSPHINE IN SYNTHESIS AND TRANSFORMATION OF NATURAL-PRODUCTS [J].
MITSUNOBU, O .
SYNTHESIS-STUTTGART, 1981, (01) :1-28